Were the Hinge Health (HNGE) share sales made directly by Robinson Elliott?

No. The sales were executed by Bessemer Venture Partners X L.P. and Bessemer Venture Partners X Institutional L.P. Elliott has an indirect economic interest through partnerships and disclaims beneficial ownership except for any pecuniary interest in those funds.

Bessemer funds tied to Hinge Health (NASDAQ: HNGE) report multi-day share sales

Q: Who is the reporting person in the Hinge Health (HNGE) Form 4 and what is his role?

The reporting person is Robinson Elliott , a partner at Bessemer Venture Partners and a director of Hinge Health. His interest in the reported HNGE shares is indirect and passive through Bessemer-related investment entities.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Hinge Health, Inc. disclosed that investment funds affiliated with Bessemer Venture Partners sold Class A Common Stock in open-market transactions. On May 7, 2026, Bessemer Venture Partners X L.P. sold 154,740 shares and Bessemer Venture Partners X Institutional L.P. sold 145,260 shares at a weighted average price of $54.77 per share, in multiple trades between $54.10 and $55.00. On May 8, 2026, the same funds sold 103,160 and 96,840 shares, respectively, at a weighted average price of $55.16, with trade prices ranging from $55.04 to $56.02. Reporting person Robinson Elliott, a partner at Bessemer Venture Partners, has an indirect, passive economic interest in these holdings and disclaims beneficial ownership except to the extent of any pecuniary interest.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Robinson Elliott

Role null

Sold 0 shs ($0.00)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	0	$0.00	--
Sale	Class A Common Stock	0	$0.00	--

Holdings After Transaction: Class A Common Stock — 0 shares (Indirect, See footnote)

Footnotes (1)

On May 7, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 154,740 and 145,260 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $54.77. These shares were sold in multiple transactions at prices ranging from $54.10 to $55.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. On May 8, 2026, BVP X and BVP X Inst sold 103,160 and 96,840 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $55.16. These shares were sold in multiple transactions at prices ranging from $55.04 to $56.02. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.

Key Figures

Shares sold May 7 by BVP X: 154,740 shares Shares sold May 7 by BVP X Inst: 145,260 shares Weighted avg price May 7: $54.77 per share +3 more

6 metrics

Shares sold May 7 by BVP X 154,740 shares Class A Common Stock sold on May 7, 2026

Shares sold May 7 by BVP X Inst 145,260 shares Class A Common Stock sold on May 7, 2026

Weighted avg price May 7 $54.77 per share Sales on May 7, 2026; trades $54.10–$55.00

Shares sold May 8 by BVP X 103,160 shares Class A Common Stock sold on May 8, 2026

Shares sold May 8 by BVP X Inst 96,840 shares Class A Common Stock sold on May 8, 2026

Weighted avg price May 8 $55.16 per share Sales on May 8, 2026; trades $55.04–$56.02

Key Terms

weighted average price, beneficial ownership, pecuniary interest, indirect, passive economic interest

4 terms

weighted average price financial

"sold 154,740 and 145,260 shares of Class A Common Stock ... at a weighted average price of $54.77."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

beneficial ownership financial

"The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

pecuniary interest financial

"except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds."

indirect, passive economic interest financial

"The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds."

Form 4 Insider Transactions: What Each Field Means →

05/11/2026 - 08:22 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Robinson Elliott

(Last)

(First)

(Middle)

C/O BESSEMER VENTURE PARTNERS

1865 PALMER AVENUE, SUITE 104

(Street)

LARCHMONT

NEW YORK

10538

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	05/07/2026		S		0⁽¹⁾	D	$0	0	I	See footnote⁽¹⁾⁽³⁾
Class A Common Stock	05/08/2026		S		0⁽¹⁾	D	$0	0	I	See footnote⁽²⁾⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On May 7, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 154,740 and 145,260 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $54.77. These shares were sold in multiple transactions at prices ranging from $54.10 to $55.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

2. On May 8, 2026, BVP X and BVP X Inst sold 103,160 and 96,840 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $55.16. These shares were sold in multiple transactions at prices ranging from $55.04 to $56.02. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.

	/s/ Augie Wilkinson, Attorney-in-Fact	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider activity did Hinge Health (HNGE) report in this Form 4?

The filing reports open-market sales of Hinge Health Class A Common Stock by two Bessemer Venture Partners funds. They sold multiple share blocks on May 7 and May 8, 2026, at weighted average prices around $54.77 and $55.16 per share.

How many Hinge Health (HNGE) shares did the Bessemer funds sell and at what prices?

On May 7, 2026, the funds sold 154,740 and 145,260 shares at a weighted average price of $54.77. On May 8, 2026, they sold 103,160 and 96,840 shares at a weighted average price of $55.16, across disclosed intraday price ranges.

Who is the reporting person in the Hinge Health (HNGE) Form 4 and what is his role?

The reporting person is Robinson Elliott, a partner at Bessemer Venture Partners and a director of Hinge Health. His interest in the reported HNGE shares is indirect and passive through Bessemer-related investment entities.

What price ranges applied to the May 7 and May 8 Hinge Health (HNGE) sales?

On May 7, 2026, trades occurred between $54.10 and $55.00 per share. On May 8, 2026, trades ranged from $55.04 to $56.02, with separate weighted average prices reported for each day’s transactions.

Does the Hinge Health (HNGE) Form 4 disclose detailed trade breakdowns for each price level?

It does not list every individual trade. Instead, it provides weighted average prices and price ranges, and states the reporting person will provide full trade details, including shares sold at each price, upon request to specified parties.